Enovis Corp (ENOV)

Apr 2, 2025, 6:30 AM EDT - 20 hours ago

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Mar 25, 2025, 8:00 AM EDT - 8 days ago

Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

Mar 5, 2025, 4:05 PM EST - 4 weeks ago

Enovis to Participate in Upcoming Investor Conferences

Feb 28, 2025, 8:23 AM EST - 4 weeks ago

Enovis Continues To Languish Despite Decent Financial Results

Feb 26, 2025, 12:53 PM EST - 5 weeks ago

Enovis Corporation (ENOV) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 6:01 AM EST - 5 weeks ago

Enovis Announces Fourth Quarter and Full Year 2024 Results

Feb 26, 2025, 6:00 AM EST - 5 weeks ago

Enovis Announces Planned CEO Succession Process

Jan 17, 2025, 6:00 AM EST - 2 months ago

Enovis™ Announces Leadership Change to International Surgical Business

Jan 7, 2025, 6:19 PM EST - 3 months ago

Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600

Jan 6, 2025, 4:15 PM EST - 3 months ago

Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Nov 22, 2024, 12:17 PM EST - 4 months ago

Enovis Corporation: Reasonably Valued With Caveats

Nov 6, 2024, 12:50 PM EST - 5 months ago

Enovis Corporation (ENOV) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 6:00 AM EST - 5 months ago

Enovis Announces Third Quarter 2024 Results

Oct 10, 2024, 7:00 AM EDT - 6 months ago

Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

Oct 3, 2024, 3:39 PM EDT - 6 months ago

Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says

Sep 9, 2024, 3:50 PM EDT - 7 months ago

Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies

Aug 20, 2024, 8:00 AM EDT - 8 months ago

Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

Aug 19, 2024, 8:00 AM EDT - 8 months ago

Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability

Aug 7, 2024, 6:00 AM EDT - 8 months ago

Enovis Announces Second Quarter 2024 Results

Jul 25, 2024, 6:00 AM EDT - 8 months ago

Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

Jul 16, 2024, 7:00 AM EDT - 9 months ago

Enovis to Host Second Quarter 2024 Results Conference Call on August 7th

Jul 15, 2024, 12:58 AM EDT - 9 months ago

Enovis Languishing Despite Respectable Performance

Jul 12, 2024, 8:00 AM EDT - 9 months ago

Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®

Jun 21, 2024, 8:22 AM EDT - 10 months ago

Top 3 Health Care Stocks That Could Blast Off In June

PEN RGEN

May 2, 2024, 2:24 PM EDT - 11 months ago

Enovis Corporation (ENOV) Q1 2024 Earnings Call Transcript

May 2, 2024, 6:00 AM EDT - 11 months ago

Enovis Announces First Quarter 2024 Results

Apr 17, 2024, 7:00 AM EDT - 1 year ago

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Feb 22, 2024, 12:14 PM EST - 1 year ago

Enovis Corporation (ENOV) Q4 2023 Earnings Call Transcript

Feb 22, 2024, 6:00 AM EST - 1 year ago

Enovis Announces Fourth Quarter and Full Year 2023 Results

Feb 12, 2024, 11:30 AM EST - 1 year ago

Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting

Feb 7, 2024, 4:15 PM EST - 1 year ago

Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Jan 26, 2024, 6:00 AM EST - 1 year ago

Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd

Jan 25, 2024, 8:30 AM EST - 1 year ago

Enovis Introduces the DonJoy ROAM™ OA Knee Brace

Jan 3, 2024, 6:00 AM EST - 1 year ago

Enovis Completes Acquisition of LimaCorporate S.p.A

Dec 28, 2023, 5:00 AM EST - 1 year ago

Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Dec 5, 2023, 6:00 AM EST - 1 year ago

Enovis Announces Business Segment Leadership Transition Plan

Nov 16, 2023, 4:15 PM EST - 1 year ago

Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference

Nov 7, 2023, 11:32 AM EST - 1 year ago

Enovis Corporation (ENOV) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 6:00 AM EST - 1 year ago

Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook

Oct 20, 2023, 6:00 AM EDT - 1 year ago

ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028

Oct 19, 2023, 6:58 AM EDT - 1 year ago

Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023

Oct 19, 2023, 6:51 AM EDT - 1 year ago

Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior Notes

Oct 16, 2023, 7:00 AM EDT - 1 year ago

Enovis to Host Third Quarter 2023 Results Conference Call on November 7th

Sep 27, 2023, 1:23 PM EDT - 1 year ago

Enovis Making Good Choices, But Not Seeing The Rewards

Sep 25, 2023, 6:14 AM EDT - 1 year ago

Enovis to acquire implant maker LimaCorporate for 800 million euros in cash and stock

Sep 25, 2023, 6:00 AM EDT - 1 year ago

Enovis to Acquire LimaCorporate S.p.A.

Sep 25, 2023, 5:02 AM EDT - 1 year ago

Enovis to buy prosthetic implants maker LimaCorporate for $850 mln

Sep 18, 2023, 8:30 AM EDT - 1 year ago

Enovis Debuts New Foot & Ankle Offerings at the AOFAS Annual Meeting

Aug 6, 2023, 12:31 AM EDT - 1 year ago

Enovis Corporation (ENOV) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 6:00 AM EDT - 1 year ago

Enovis Announces Second Quarter 2023 Results and Raises Full-Year Outlook